TriIs raised its net income forecast for the year ending December 2026 to ¥155mn from ¥104mn, a 48.1% increase. The important qualifier is that the operating outlook barely moved at all: revenue remains ¥1.416bn, operating loss stays at ¥22mn, and ordinary loss stays at ¥5mn. In other words, the upgrade comes from planned extraordinary gains, not from a better trading year.
| Metric | Previous forecast | Revised forecast |
|---|---|---|
| Revenue | ¥1.416bn | ¥1.416bn |
| Operating loss | -¥22mn | -¥22mn |
| Ordinary loss | -¥5mn | -¥5mn |
| Net income | ¥104mn | ¥155mn |
| EPS | ¥13.34 | ¥19.77 |
The company said it expects to book ¥76mn of extraordinary gains in second-quarter results, made up of a ¥62mn gain from reversing stock acquisition rights and ¥14mn in compensation related to excessive spending. TriIs tied those items to a Tokyo High Court outcome in litigation involving former representative director Yukiko Ikeda, saying the lower-court judgment was maintained.
That is why the headline number improved while the rest of the income statement stayed gloomy. Reported net income goes up, but TriIs is still guiding to losses at both the operating and ordinary levels.
One caveat remains. In a separate same-day notice, TriIs said it would continue to defend its position if Ikeda files a further appeal.